Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
No current S&P 500 role.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
No current colleagues on record.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2021 | MRNA | Sale | 6,600 | $174.20 | $1.1M |
| May 25, 2021 | MRNA | Sale | 6,600 | $166.58 | $1.1M |
| May 20, 2021 | MRNA | Sale | 6,600 | $159.92 | $1.1M |
| May 18, 2021 | MRNA | Sale | 6,600 | $160.16 | $1.1M |
| May 13, 2021 | MRNA | Sale | 6,600 | $152.60 | $1.0M |
| May 11, 2021 | MRNA | Sale | 6,600 | $151.31 | $999K |
| May 6, 2021 | MRNA | Sale | 6,600 | $147.82 | $976K |
| May 4, 2021 | MRNA | Sale | 6,600 | $185.25 | $1.2M |
| Apr 29, 2021 | MRNA | Sale | 6,600 | $182.49 | $1.2M |
| Apr 27, 2021 | MRNA | Sale | 6,600 | $178.29 | $1.2M |
| Apr 22, 2021 | MRNA | Sale | 6,600 | $168.26 | $1.1M |
| Apr 20, 2021 | MRNA | Sale | 6,600 | $160.32 | $1.1M |
| Apr 15, 2021 | MRNA | Sale | 6,600 | $158.76 | $1.0M |
| Apr 13, 2021 | MRNA | Sale | 6,600 | $146.62 | $968K |
| Apr 8, 2021 | MRNA | Sale | 6,600 | $132.85 | $877K |
| Apr 6, 2021 | MRNA | Sale | 6,600 | $130.01 | $858K |
| Apr 1, 2021 | MRNA | Sale | 6,600 | $132.51 | $875K |
| Mar 30, 2021 | MRNA | Sale | 6,600 | $123.30 | $814K |
| Mar 25, 2021 | MRNA | Sale | 6,600 | $126.88 | $837K |
| Mar 23, 2021 | MRNA | Sale | 6,600 | $145.55 | $961K |
| Mar 18, 2021 | MRNA | Sale | 6,600 | $144.39 | $953K |
| Mar 16, 2021 | MRNA | Sale | 6,600 | $148.50 | $980K |
| Mar 11, 2021 | MRNA | Sale | 6,600 | $133.29 | $880K |
| Mar 9, 2021 | MRNA | Sale | 6,600 | $127.11 | $839K |
| Mar 4, 2021 | MRNA | Sale | 6,600 | $128.58 | $849K |
| Mar 2, 2021 | MRNA | Sale | 6,600 | $153.77 | $1.0M |
| Oct 21, 2020 | MRNA | Sale | 14,148 | $69.84 | $988K |
| Oct 21, 2020 | MRNA | Sale | 700 | $71.39 | $50K |
| Oct 21, 2020 | MRNA | Sale | 1,697 | $68.70 | $117K |
| Oct 21, 2020 | MRNA | Sale | 15,455 | $70.56 | $1.1M |
| Jun 18, 2020 | MRNA | Sale | 64,000 | $63.03 | $4.0M |
| May 20, 2020 | MRNA | Sale | 64,000 | $70.00 | $4.5M |
SEC reporting-owner ID (CIK) 1221127 · all filings on EDGAR